Korean listed company 950260950260
Korean listed company 950260 (950260) Material Information, 2026-09-28
Filing date ·
The company filed an application with the U.S. FDA for a 1/2a phase clinical trial of IGT-303, a chronic kidney disease treatment.
Sign in to read this filing in detail
Continue to the filing details and any available analysis after signing in.
Filing lists and official source links are available without signing in.